Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04108858
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8HER2-Positive Breast CarcinomaMetastatic Breast Carcinoma
National Cancer Institute (NCI) 2
Post-approval studies (Phase 4)Study completedNCT02405858
What this trial is testing

Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Janssen Pharmaceutical K.K. 51
Large-scale testing (Phase 3)Looking for participantsNCT07296458
What this trial is testing

FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

Who this might be right for
Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases 132
Not applicableStudy completedNCT04392193
What this trial is testing

Proton Particle Therapy for Cardiac Arrhythmia

Who this might be right for
Cardiac Arrhythmia
Konstantinos Siontis 8
Not applicableStudy completedNCT06607393
What this trial is testing

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

Who this might be right for
Metastatic Nonsmall Cell Lung Cancer
Aetion, Inc. 851
Post-approval studies (Phase 4)Study completedNCT01419249
What this trial is testing

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study

Who this might be right for
Idiopathic Growth Hormone DeficiencyTurner Syndrome
Merck KGaA, Darmstadt, Germany 458
Not applicableStudy completedNCT07167511
What this trial is testing

Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

Who this might be right for
Helicobacter Pylori Infection
Yueyue Li 1,730
Not applicableStudy completedNCT03863093
What this trial is testing

Evaluation of Air Polishing With Ultrasonic Debridement in the Treatment of Initial Periodontal Pockets

Who this might be right for
Gingivitis
Syrian Private University 13
Testing effectiveness (Phase 2)Study completedNCT00005649
What this trial is testing

Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT00682578
What this trial is testing

A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan

Who this might be right for
Uncomplicated Falciparum MalariaVivax Malaria
University of Oxford 1,086
Not applicableWithdrawnNCT01434550
What this trial is testing

Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Tumor
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT00845910
What this trial is testing

Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 22
Testing effectiveness (Phase 2)Study completedNCT04224740
What this trial is testing

Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer

Who this might be right for
Penile Carcinoma
Latin American Cooperative Oncology Group 37
Testing effectiveness (Phase 2)Ended earlyNCT00570258
What this trial is testing

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Who this might be right for
Metastatic Breast Cancer
University of Arkansas 27
Testing effectiveness (Phase 2)Study completedNCT04144608
What this trial is testing

Toripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLC

Who this might be right for
Advanced Non Small Cell Lung Cancer
Yongchang Zhang 40
Not applicableStudy completedNCT05319340
What this trial is testing

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Who this might be right for
Anticoagulants
I.M. Sechenov First Moscow State Medical University 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04924413
What this trial is testing

L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Quanli Gao 9
Testing effectiveness (Phase 2)Study completedNCT00615758
What this trial is testing

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04021108
What this trial is testing

Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)

Who this might be right for
Gastroesophageal Adenocarcinoma
Weill Medical College of Cornell University 80
Testing effectiveness (Phase 2)Study completedNCT00425191
What this trial is testing

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer
Sanofi 165
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation